FEATURES | This report | Banka, Chervinsky et al, 2010A | Boztug et al, 2009 | Arostegui et al, 2009 | Xia et al, 2009 | Banka, Newman et al, 2010B | Germes-hausen et al, 2010 | Boztug, Rosenberg et al, 2012 | Smith et al, 2012 | Alizadeh et al., 2011 | McDerm-ott et al, 2010 | Gatti et al, 2011 | Milá et al., 2011 | Total |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
(n=2) | (n=4) | (n=12) | (n=1) | (n=2) | (n=2) | (n=2) | (n=16) | (n=4)C | (n=2) | (n=2D) | (n=1) | (n=1) | (n=51) | |
Cardiac | ||||||||||||||
Atrial septal defect | 2/2 | 2/4 | 7/12 | 1/1 | 2/2E | 2/2 | 2/2 | 15/16 | 1/4 | 2/2 | 1/2 | 1/1 | 0/1 | 38/51 |
PDA | 0/2 | 2/4 | 1/12 | 0/1 | 0/2 | 0/2 | 0/2 | 2/16 | 0/4 | 0/2 | 0/2 | 0/1 | 0/1 | 5/51 |
Valvular defects | 1/2 | 1/4F | 2/12G | 0/1 | 0/2 | 0/2 | 1/2H | 4/16I | 1/4J | 0/2 | 1/2K | 1/1L | 0/1 | 12/51 |
Hypoplastic left heart | 0/2 | 0/4 | 0/12 | 0/1 | 0/2 | 0/2 | 0/2 | 1/16 | 0/4 | 0/2 | 0/2 | 0/1 | 0/1 | 1/51 |
Other | 0/2 | 0/4 | 0/12 | 0/1 | 1/2E | 0/2 | 0/2 | 0/16 | 1/4J | 0/2 | 1/2K | 0/1 | 1/1M | 4/51 |
Pulmonary | ||||||||||||||
Pulmonary hypertension | 1/2 | 1/4N | 0/12 | 0/1 | 0/2 | 2/2O | 0/2 | 0/16 | 0/4 | 0/2 | 1/2K | 0/1 | 0/1 | 5/51 |
Other | 0/2 | 0/4 | 1/12P | 0/1 | 0/2 | 0/2 | 0/2 | 0/16 | 0/4 | 0/2 | 0/2 | 0/1 | 0/1 | 1/51 |
Birth defects | ||||||||||||||
Cryptorchidism | 1/1 | 1/2 | 4/6 | 1/1 | 0/2Q | 1/1 | 1/1 | 5/11 | 0/3 | 0/2 | 1/1 | 1/1 | 1/1 | 17/33 |
Other genital | 0/2 | 0/4 | 1/12R | 0/1 | 0/2 | 0/2 | 1/2S | 4/16T | 0/4 | 0/2 | 0/2 | 0/1 | 0/1 | 6/51 |
Renal/ureters | 1/2 | 1/4U | 1/12V | 0/1 | 0/2 | 0/2 | 0/2 | 6/16 | 0/4 | 1/2 | 0/2 | 0/1 | 0/1 | 10/51 |
Cleft palate | 0/2 | 0/4 | 1/12 | 0/1 | 0/2 | 0/2 | 0/2 | 0/16 | 0/4 | 0/2 | 0/2 | 0/1 | 0/1 | 1/51 |
Other | 0/2 | 1/4W | 0/12 | 0/1 | 0/2 | 2/2X | 0/2 | 4/16Y | 0/4 | 0/2 | 0/2 | 0/1 | 0/1 | 7/51 |
Features in infancy/childhood | ||||||||||||||
Prominent skin venous pattern | 2/2 | 4/4 | 10/12 | 1/1 | NA | NA | 2/2 | 14/16 | 0/4 | 1/2 | 2/2 | 1/1 | 1/1 | 38/47 |
Poor growth/FTT | 0/2 | 4/4 | 3/12 | 1/1 | NA | 2/2 | 1/2 | 7/16 | 1/4 | 1/2 | 2/2 | 0/1 | 0/1 | 22/49 |
Microcephaly (relative) | 0/2 | 0/4 | 2/12 | 0/1 | NA | 0/2 | 1/2 | 0/16 | 0/4 | 0/2 | 2/2 | 0/1 | 0/1 | 5/49 |
DD/LD | 0/2 | 4/4 | NA | 1/1 | NA | NA | 1/2 | 2/16 | 0/4 | NA | 0/2 | 0/1 | 0/1 | 8/33 |
SNHL or hearing loss | 0/2 | 0/4 | 2/12 | 0/1 | NA | NA | 1/2 | 2/16 | 0/4 | 0/2 | 2/2 | 1/1 | 0/1 | 8/47 |
Features in adolescence /adulthood | ||||||||||||||
Varicose veins | 2/2 | 3/3 | NA | NA | NA | NA | NA | 0/5 | 0/2 | NA | NA | NA | NA | 5/12 |
Delayed puberty | 0/2 | 2/3 | NA | NA | NA | NA | 1/2Z | 2/5 | 0/2 | NA | NA | NA | NA | 5/14 |
Intellectual disability | 0/2 | 3/3 | NA | NA | NA | NA | 1/2 | 0/5 | 0/2 | NA | NA | NA | NA | 4/14 |
Short stature | 0/2 | 3/3 | NA | NA | NA | NA | 1/2 | 1/1 | 1/2 | NA | NA | NA | NA | 6/10 |
Crohn diseaseAA | 2/2 | 0/3 | NA | 0/1 | NA | NA | 0/2 | NA | 2/3 | NA | NABB | NA | NA | 4/11 |
Features in childhood or adulthood | ||||||||||||||
Growth Hormone deficiency | 0/2 | 0/4 | 0/12 | 0/1 | 0/2 | 0/2 | 0/2 | 2/16 | 0/4 | 0/2 | 0/2 | 0/1 | 0/1 | 2/51 |
Hepatomegaly &/or splenomegaly | 2/2 | NA | 3/12 | 0/1 | 0/2 | 1/2 | 0/2 | 2/16 | 1/4 | 0/2 | 0/2 | 0/1 | 0/1 | 9/47 |
Thrombocytopenia | 2/2 | 1/3 | 5/12 | 1/1 | 2/2 | 2/2 | 2/2 | 10/16 | 0/4 | 0/2 | 2/2 | 1/1 | 1/1 | 29/50 |
Patients > age 18 years | 1M (37yr) | 1M (26 yr) | 0/12 | 1M (22yr) | Ages not given | 0/2 | 1 M (20yr) | 0/16 | 2MCC (30yr, 23 yr) | 0/2 | 0/2 | 0/1 | 0/1 | 10/51 |
1 F (38yr) | 2F (29 yr, 25 yr) | 1F (24yr) |